Skip to main content

Table 2 Univariate and multivariate analysis of overall survival in 344 HCC patients

From: Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma

Variables

Univariate analysis

Multivariate analysis

Hazard Ratio

CI 95%

P

Hazard Ratio

CI 95%

P

Age (≤60 / > 60)

1.02

1–1.04

0.024*

1.02

1–1.04

0.05

Gender (M / F)

1.43

0.9–2.26

0.129

   

Grade (I + II / III + IV)

1.16

0.92–1.46

0.218

   

AJCC stage (I + II / III + IV)

1.23

0.96–1.58

0.102

   

COMMD1 (high / low)

1.14

0.72–1.79

0.579

   

COMMD2 (high / low)

0.97

0.61–1.55

0.903

   

COMMD3 (high / low)

2.37

1.48–3.8

0.000*

2.16

1.33–3.48

0.002*

COMMD4 (high / low)

1.07

0.67–1.69

0.788

   

COMMD5 (high / low)

1.65

1.05–2.59

0.029*

1.33

0.83–2.12

0.233

COMMD6 (high / low)

1.23

0.76–1.99

0.398

   

COMMD7 (high / low)

0.82

0.5–1.34

0.437

   

COMMD8 (high / low)

1.5

0.94–2.4

0.091

   

COMMD9 (high / low)

1.44

0.89–2.31

0.137

   

COMMD10 (high / low)

1.06

0.67–1.68

0.794

   
  1. HCC Hepatocellular carcinoma, CI Confidence interval. * p < 0.05.